The focus remains on BPC-157 compound identity, COA review, analytical testing, peptide purity, lot traceability, research-use-only labeling, product documentation, and published literature boundaries
The GLP-1 Gold Rush: Efficacy Meets Exorbitant Costs GLP-1 medications have demonstrated remarkable efficacy in treating type 2 diabetes and obesity, leading to significant weight loss in many patients
Peer review Peer review information Nature Medicine thanks Naveed Sattar and the other, anonymous, reviewer(s) for their contribution to the peer review of this work
Small molecules may offer advantages in terms of ease of administration and production costs, potentially making obesity treatment more accessible to a broader population